The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Safety and feasibility of adjuvant chemotherapy with S-1 in Korean patients with curatively resected advanced gastric cancer.
Jae Ho Jeong
No relevant relationships to disclose
Min-Hee Ryu
No relevant relationships to disclose
Sung Sook Lee
No relevant relationships to disclose
Baek-Yeol Ryoo
No relevant relationships to disclose
Sang Hong Lee
No relevant relationships to disclose
Kab Choong Kim
No relevant relationships to disclose
Jeong Hwan Yook
No relevant relationships to disclose
Sung Tae Oh
No relevant relationships to disclose
Byung Sik Kim
No relevant relationships to disclose
Yoon-Koo Kang
No relevant relationships to disclose